Titre : Antimétabolites

Antimétabolites : Questions médicales fréquentes

Termes MeSH sélectionnés :

Evidence-Based Practice
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Antimétabolites : Questions médicales les plus fréquentes", "headline": "Antimétabolites : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Antimétabolites : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-11", "dateModified": "2025-04-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Antimétabolites" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Noxas", "url": "https://questionsmedicales.fr/mesh/D009676", "about": { "@type": "MedicalCondition", "name": "Noxas", "code": { "@type": "MedicalCode", "code": "D009676", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.888.569" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antimétabolites antinéoplasiques", "alternateName": "Antimetabolites, Antineoplastic", "url": "https://questionsmedicales.fr/mesh/D000964", "about": { "@type": "MedicalCondition", "name": "Antimétabolites antinéoplasiques", "code": { "@type": "MedicalCode", "code": "D000964", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.888.569.042.030" } } } ], "about": { "@type": "MedicalCondition", "name": "Antimétabolites", "alternateName": "Antimetabolites", "code": { "@type": "MedicalCode", "code": "D000963", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "John A Gonzales", "url": "https://questionsmedicales.fr/author/John%20A%20Gonzales", "affiliation": { "@type": "Organization", "name": "F.I. Proctor Foundation, University of California, San Francisco, California; Department of Ophthalmology, University of California, San Francisco, California." } }, { "@type": "Person", "name": "Radhika Thundikandy", "url": "https://questionsmedicales.fr/author/Radhika%20Thundikandy", "affiliation": { "@type": "Organization", "name": "Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India." } }, { "@type": "Person", "name": "Anuradha Kanakath", "url": "https://questionsmedicales.fr/author/Anuradha%20Kanakath", "affiliation": { "@type": "Organization", "name": "Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Coimbatore, India." } }, { "@type": "Person", "name": "Hassan A Al-Dhibi", "url": "https://questionsmedicales.fr/author/Hassan%20A%20Al-Dhibi", "affiliation": { "@type": "Organization", "name": "Division of Vitreoretinal Surgery and Uveitis, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia." } }, { "@type": "Person", "name": "Nisha R Acharya", "url": "https://questionsmedicales.fr/author/Nisha%20R%20Acharya", "affiliation": { "@type": "Organization", "name": "F.I. Proctor Foundation, University of California, San Francisco, California; Department of Ophthalmology, University of California, San Francisco, California; Department of Epidemiology and Biostatistics, University of California, San Francisco, California. Electronic address: nisha.acharya@ucsf.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Psychometric Evaluation of a Measure of Evidence-Based Practice in Occupational Health.", "datePublished": "2024-10-24", "url": "https://questionsmedicales.fr/article/39450632", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.23749/mdl.v115i5.16286" } }, { "@type": "ScholarlyArticle", "name": "Change in orthopaedic surgeon behaviour by implementing evidence-based practice.", "datePublished": "2023-05-16", "url": "https://questionsmedicales.fr/article/37341352", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": null } }, { "@type": "ScholarlyArticle", "name": "Reducing the incidence of stroke-associated pneumonia: an evidence-based practice.", "datePublished": "2022-08-11", "url": "https://questionsmedicales.fr/article/35953801", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12883-022-02826-8" } }, { "@type": "ScholarlyArticle", "name": "Adaptation and validation of the Evidence-based Practice Profile Questionnaire (EBP", "datePublished": "2023-08-21", "url": "https://questionsmedicales.fr/article/37605185", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12909-023-04594-6" } }, { "@type": "ScholarlyArticle", "name": "Investigating the influencing factors of evidence-based healthcare practice adoption.", "datePublished": "2024-09-12", "url": "https://questionsmedicales.fr/article/39354780", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4102/curationis.v47i1.2586" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions toxiques", "item": "https://questionsmedicales.fr/mesh/D004786" }, { "@type": "ListItem", "position": 4, "name": "Noxas", "item": "https://questionsmedicales.fr/mesh/D009676" }, { "@type": "ListItem", "position": 5, "name": "Antimétabolites", "item": "https://questionsmedicales.fr/mesh/D000963" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Antimétabolites - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Antimétabolites", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Antimétabolites", "description": "Comment diagnostique-t-on une toxicité aux antimétabolites ?\nQuels tests sont utilisés pour évaluer l'efficacité des antimétabolites ?\nQuels signes cliniques indiquent une surdose d'antimétabolites ?\nComment évaluer les effets secondaires des antimétabolites ?\nQuels marqueurs tumoraux sont surveillés lors d'un traitement ?", "url": "https://questionsmedicales.fr/mesh/D000963?mesh_terms=Evidence-Based+Practice&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Antimétabolites", "description": "Quels sont les symptômes courants des effets secondaires ?\nComment les antimétabolites affectent-ils le système immunitaire ?\nQuels symptômes indiquent une réaction allergique ?\nLes antimétabolites causent-ils des douleurs ?\nQuels symptômes peuvent indiquer une anémie due aux antimétabolites ?", "url": "https://questionsmedicales.fr/mesh/D000963?mesh_terms=Evidence-Based+Practice&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Antimétabolites", "description": "Comment prévenir les effets secondaires des antimétabolites ?\nY a-t-il des mesures préventives avant le traitement ?\nComment gérer les nausées induites par les antimétabolites ?\nQuelles précautions prendre lors de l'administration ?\nLes patients doivent-ils être informés des effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D000963?mesh_terms=Evidence-Based+Practice&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Antimétabolites", "description": "Quels types d'antimétabolites existent ?\nComment sont administrés les antimétabolites ?\nQuels sont les traitements combinés avec les antimétabolites ?\nQuelle est la durée typique d'un traitement par antimétabolites ?\nLes antimétabolites sont-ils utilisés en traitement adjuvant ?", "url": "https://questionsmedicales.fr/mesh/D000963?mesh_terms=Evidence-Based+Practice&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Antimétabolites", "description": "Quelles sont les complications possibles des antimétabolites ?\nLes antimétabolites peuvent-ils causer des cancers secondaires ?\nComment gérer une infection due à l'immunosuppression ?\nQuels sont les risques de toxicité hépatique ?\nComment prévenir les complications liées aux antimétabolites ?", "url": "https://questionsmedicales.fr/mesh/D000963?mesh_terms=Evidence-Based+Practice&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Antimétabolites", "description": "Quels facteurs augmentent le risque d'effets secondaires ?\nLes antécédents médicaux influencent-ils le traitement ?\nLe mode de vie affecte-t-il l'efficacité des antimétabolites ?\nLes interactions médicamenteuses sont-elles un risque ?\nLes facteurs génétiques influencent-ils la réponse au traitement ?", "url": "https://questionsmedicales.fr/mesh/D000963?mesh_terms=Evidence-Based+Practice&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une toxicité aux antimétabolites ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La toxicité est diagnostiquée par des tests sanguins et l'évaluation des symptômes cliniques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'efficacité des antimétabolites ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des biopsies tumorales et des imageries médicales sont utilisées pour évaluer la réponse au traitement." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une surdose d'antimétabolites ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des nausées, des vomissements et une fatigue extrême peuvent indiquer une surdose." } }, { "@type": "Question", "name": "Comment évaluer les effets secondaires des antimétabolites ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation se fait par l'observation clinique et des tests de laboratoire réguliers." } }, { "@type": "Question", "name": "Quels marqueurs tumoraux sont surveillés lors d'un traitement ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme le CA 19-9 ou le PSA peuvent être surveillés selon le type de cancer." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des effets secondaires ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent nausées, fatigue, perte d'appétit et troubles gastro-intestinaux." } }, { "@type": "Question", "name": "Comment les antimétabolites affectent-ils le système immunitaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer une immunosuppression, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Quels symptômes indiquent une réaction allergique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées, démangeaisons et gonflements peuvent signaler une allergie." } }, { "@type": "Question", "name": "Les antimétabolites causent-ils des douleurs ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs abdominales et musculaires peuvent survenir comme effets secondaires." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une anémie due aux antimétabolites ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, pâleur et essoufflement peuvent indiquer une anémie causée par le traitement." } }, { "@type": "Question", "name": "Comment prévenir les effets secondaires des antimétabolites ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une surveillance régulière et des ajustements de dose peuvent aider à prévenir les effets secondaires." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives avant le traitement ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests de fonction hépatique et rénale sont souvent effectués avant le traitement." } }, { "@type": "Question", "name": "Comment gérer les nausées induites par les antimétabolites ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des antiémétiques peuvent être prescrits pour gérer les nausées et vomissements." } }, { "@type": "Question", "name": "Quelles précautions prendre lors de l'administration ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Il est essentiel de suivre les protocoles d'administration pour éviter les erreurs de dosage." } }, { "@type": "Question", "name": "Les patients doivent-ils être informés des effets secondaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation des patients sur les effets secondaires est cruciale pour une bonne observance." } }, { "@type": "Question", "name": "Quels types d'antimétabolites existent ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux types incluent les analogues des purines et des pyrimidines." } }, { "@type": "Question", "name": "Comment sont administrés les antimétabolites ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être administrés par voie orale ou intraveineuse, selon le médicament." } }, { "@type": "Question", "name": "Quels sont les traitements combinés avec les antimétabolites ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont souvent combinés avec des agents alkylants ou des inhibiteurs de la tyrosine kinase." } }, { "@type": "Question", "name": "Quelle est la durée typique d'un traitement par antimétabolites ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La durée varie, mais elle est généralement de plusieurs semaines à plusieurs mois." } }, { "@type": "Question", "name": "Les antimétabolites sont-ils utilisés en traitement adjuvant ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont souvent utilisés en traitement adjuvant après chirurgie pour réduire les récidives." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des antimétabolites ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'immunosuppression, l'anémie et des troubles gastro-intestinaux." } }, { "@type": "Question", "name": "Les antimétabolites peuvent-ils causer des cancers secondaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains antimétabolites sont associés à un risque accru de cancers secondaires." } }, { "@type": "Question", "name": "Comment gérer une infection due à l'immunosuppression ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement antibiotique précoce et une surveillance étroite sont essentiels." } }, { "@type": "Question", "name": "Quels sont les risques de toxicité hépatique ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les antimétabolites peuvent provoquer une hépatotoxicité, nécessitant un suivi régulier." } }, { "@type": "Question", "name": "Comment prévenir les complications liées aux antimétabolites ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une surveillance régulière et des ajustements de traitement peuvent aider à prévenir les complications." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'effets secondaires ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, les comorbidités et les interactions médicamenteuses augmentent le risque." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le traitement ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies hépatiques ou rénales peuvent influencer le choix du traitement." } }, { "@type": "Question", "name": "Le mode de vie affecte-t-il l'efficacité des antimétabolites ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation déséquilibrée et le tabagisme peuvent réduire l'efficacité du traitement." } }, { "@type": "Question", "name": "Les interactions médicamenteuses sont-elles un risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines interactions peuvent augmenter la toxicité ou diminuer l'efficacité des antimétabolites." } }, { "@type": "Question", "name": "Les facteurs génétiques influencent-ils la réponse au traitement ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des variations génétiques peuvent affecter la métabolisation des antimétabolites." } } ] } ] }

Sources (10000 au total)

Psychometric Evaluation of a Measure of Evidence-Based Practice in Occupational Health.

Occupational Health Services (OHS) are obliged to follow the principles of evidence-based medicine. However, there needs to be tools to measure this. Therefore, we developed and validated a questionna... The questionnaire's content validity was assessed by 12 experts in the field. Then, an opportunity sample of 549 OHS practitioners completed the questionnaire. We examined the questionnaire's psychome... The content validity index of the chosen items was 0.78 or higher. Exploratory factor analysis revealed that the measure's construct validity was adequate (KMO 0.9). Principal component factor analysi... The EBP-OHS is a valid tool for measuring occupational health services' evidence-based practice and enabling the implementation of research into practice. It embodies the phases of evidence transfer a...

Change in orthopaedic surgeon behaviour by implementing evidence-based practice.

Orthopaedic practice is not always aligned with new evidence which may result in an evidence-practice gap. Our aim was to present and report the use of a new model for implementation of evidence-based... A new implementation model from the Centre for Evidence-Based Orthopaedics (CEBO) was applied. It comprises four phases: 1) baseline practice is held up against best available evidence, and barriers t... Prior to application of the CEBO model, only VLP was used in the department. Based on best evidence, the symposium found that a change in practice was justified. A local guideline stating CRPP as firs... It is feasible to change surgeons' practice according to best evidence using the CEBO model.... None.... Not relevant....

Reducing the incidence of stroke-associated pneumonia: an evidence-based practice.

Pulmonary infection is a frequent complication among stroke patients and adversely affects clinical outcomes, increases the length of hospitalization stay and costs, and aggravates the financial burde... The evidence-based practice project evaluated the effectiveness of a standard care bundle intervention in preventing the occurrence of SAP.... The project was conducted in a neurology department of a teaching hospital. Given the variation in assessment and management standards, evidence-based practice (EBP) methodology was used to establish ... A significant improvement was observed in preventing SAP in patients in the postimplementation group compared with those in the preimplementation group (14.0% vs. 37.2%, p = 0.025). In addition, signi... Evidence-based care bundles successfully empower nurses to reduce the incidence of SAP. The management flow of SAP prevention could be promoted to other units of the neurology department in the future...

Adaptation and validation of the Evidence-based Practice Profile Questionnaire (EBP

Evidence-based practice (EBP) is an essential approach of optimizing patient outcomes and driving progress in clinical practice. As an important reserve talent of medical staff and researchers, the cl... Cross-cultural modification, including translating the original EBP... The Chinese EBP... Chinese version of EBP...

Investigating the influencing factors of evidence-based healthcare practice adoption.

In healthcare facilities, evidence-based healthcare practice (EBHP) is becoming more widely acknowledged as a critical element of patient care delivery. An increasingly important component of EBHP is ... This study aims to investigate factors that influence EBHP adoption in public healthcare institutions in South Africa.... Four hundred and fifty patients were self-administered to healthcare professionals at an academic public hospital in Gauteng and used in this study. A total of 300 responses were available for use in ... Perceived ease of use (PEOU) and perceived usefulness (PU) were found to be major variables in the adoption of EBHP along with technological, organisational and environmental factors. The technology c... Perceived ease of use, PU, ORGR, and GLRS are regarded as a vital variables in the implementation of EBHP in South African public hospitals.Contribution: The study's conclusions would be helpful to po...

A Study of Medical Surgical Nurses Leaders' Evidence-Based Practice Attributes: Critical Implications for Practice.

The purpose of this study was to determine medical-surgical nurse leaders' evidence-based practice (EBP) attributes, perceived barriers to EBP, and whether there were differences in leaders' EBP compe... Leaders are crucial to the development of cultures that support EBP implementation, but little is known about medical-surgical nurse leaders' capacity to perform this aspect of their role.... A cross-sectional design using survey methodology was used. The survey contained demographic/work setting questions and 3 instruments to measure EBP beliefs, implementation, and competencies.... Senior leaders self-reported higher EBP attributes compared with nurses in other roles; nurses with an MSN or higher reported greater frequency of EBP implementation. A regression revealed that EBP co... Findings demonstrate there is a range of EBP beliefs and competencies, and barriers to EBP among medical-surgical nurse leaders. Because medical-surgical nursing is the largest acute care practice spe...

Evidence- based physiotherapy practice in Jordan: Evaluation and identification of implementation factors.

Evidence-based physiotherapy practice (EBPTP) is becoming increasingly important to improve patient outcomes and clinical decision-making in the physiotherapy profession.... To evaluate the EBPTP in Jordan and identify the barriers to its implementation in clinical practice.... The study used a cross-sectional survey of licensed physiotherapists working in Jordan using EBPTP self-reported questionnaire. Frequencies, percentages, and one sample Wilcoxon rank test were used to... A total of 210 participants completed the survey. All EBPTP questionnaire elements showed significant positive levels (p = .00) except facility support reflecting non-significant negative level (p = .... The findings confirm a clear gap in EBPTP implementation among physiotherapists in Jordan. The EBPTP implementation factors were mainly based on education sectors and work facilities. Engagement of st...

Evidence-based practice models and frameworks in the healthcare setting: a scoping review.

The aim of this scoping review was to identify and review current evidence-based practice (EBP) models and frameworks. Specifically, how EBP models and frameworks used in healthcare settings align wit... A Scoping review.... Published articles were identified through searches within electronic databases (MEDLINE, EMBASE, Scopus) from January 1990 to April 2022. The English language EBP models and frameworks included in th... Of the 20 097 articles found by our search, 19 models and frameworks met our inclusion criteria. The results showed a diverse collection of models and frameworks. Many models and frameworks were well ... Many EBP models and frameworks currently exist that provide diverse instructions on the best way to use EBP. However, the inclusion of patient values and preferences needs to be better integrated into...

Neurocheck Frequency: Determining Perceptions and Barriers to Implementation of Evidence-Based Practice.

Following acute brain injury, patients in the intensive care unit often undergo hourly or every-other-hour exams ("neurochecks") to monitor for neurodeterioration. We assessed health care provider att... This was a cross-sectional, online survey distributed in Spring 2021 at a tertiary care academic medical center. Providers from multiple intensive care unit and neuroscience clinical specialties inclu... Among 177 participants, 61 (34%) and 116 (66%) were self-identified as ordering and performing providers, respectively. The survey response rate was 58% among physicians and 51% among bedside nurses w... This survey revealed clinically relevant differences in ordering versus performing provider attitudes about frequent neurochecks. Providers preferred every-other-hour rather than hourly neurochecks....